StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Zero confidence in this CEO

<< Previous

Bullboard Posts

Next >>

Comment by Jonnyboy85on Jun 25, 2021 10:20pm

126 Views

Post# 33455184

RE:Zero confidence in this CEO

My God will you guys give it up already? Grail is 50% accurate, a coin toss, if you have it or don't. "Overall sensitivity for cancer signal detection was 51.5% (49.6% to 53.3%)"

LittleGuy2 wrote: Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set - Annals of Oncology

Glass half full...
at least this Grail sponsored study may bring attention to the cancer detection space.

Glass half empty...
Tripp's leadersip has squandered a 2 year jump on Grail because he couldn't set up a study with a group of physician-scientists that would give the medical community some evidence they could follow complete with world-wide media attention.

If you can't download the article just check the Guardian or the CBC, or any other news outlet on the planet.